Double pneumonia is treatable in most cases. Here's why it can turn deadly fast, even in someone young and seemingly healthy ...

The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug ...

Some Americans seem to be extra-alarmed about Ebola and hantavirus in the wake of COVID-19. But public health experts say ...

Early driving pressure trajectories in patients with COVID-19 ARDS are independently associated with the risk for prolonged mechanical ventilation.

Objective In order to predict at hospital admission the prognosis of patients with serious and life-threatening COVID-19 pneumonia, we sought to understand the clinical characteristics of hospitalised ...

Community-acquired pneumonia (CAP) remains a substantial global health challenge. In the UK alone, more than 200 000 hospital admissions occur annually, with a substantially larger volume of cases ...

The outbreak began in early April on a cruise ship. Now health authorities around the world are working to contain it. Here's what infectious disease experts have to say.

In severe viral pneumonia, bacterial and fungal superinfections are dangerous and require multiple diagnostic and treatment approaches, an international group of researchers advises. In their ...

Severe pneumonia-associated lung injury remains a critical focus in infection and immunology research due to its high lethality and complex immunopathology. Affected patients often present with ...

In our current health care environment, hospitals and health care providers are challenged to provide a high standard of care in a more efficient way. Multiple evidence-based practice guidelines ...

A French team has identified biological markers that can predict 3‑month mortality in patients hospitalized for initially mild COVID pneumonia. The researchers developed a predictive score based on ...

Scientists in the United States say they may be inching closer to a long-sought goal in medicine: a single vaccine capable of protecting against multiple respiratory threats, from COVID-19 and the flu ...